Understanding Vape Counter-Marketing Study
Countering E-Cigarette Marketing in the Retail Environment Among Adolescents and Young Adults
The goal of this interventional study is to test whether short videos of electronic-cigarette (e-cigarette) counter-marketing lessons work to decrease people's intent to use and smoke e-cigarettes. Using short videos, the investigators hope to inform participants about the marketing strategies that e-cigarette companies use to try to get people to purchase and use e-cigarettes. The investigators hope to find that, after watching the short videos, people will be able to point out when e-cigarette companies are trying to sell their products, and hopefully they will have a lower interest in buying and using e-cigarettes. The investigators also hope participants will learn more about the addictiveness and harmfulness of using e-cigarettes by watching the short videos.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Shivani Gaiha, PhD
- Numero di telefono: 617-355-3538
- Email: Shivani.Gaiha@childrens.harvard.edu
Backup dei contatti dello studio
- Nome: Madison O'Connell
- Numero di telefono: 617-919-6964
- Email: madison.oconnell@childrens.harvard.edu
Luoghi di studio
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02115
- Boston Children's Hospital
-
Contatto:
- Shivani Gaiha, PhD
- Numero di telefono: 617-355-3538
- Email: shivani.gaiha@childrens.harvard.edu
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- 13-21 years old
- Fluent in English
- Owns a smartphone or other device that can be used to complete study activities (e.g., watching videos, responding to electronic surveys)
- Meets sampling ratio to match the US Census for sex assigned at birth, race, and ethnicity
Exclusion Criteria:
- Fails survey validation checks (e.g., completing the survey too quickly, providing the same answer to every question)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: New Intervention Group
Participants in this arm will receive a novel intervention developed by the study team. |
Participants will view 4 short-form videos filmed by influencers. Influencers convey messaging designed to counter e-cigarette marketing in retail stores. |
|
Comparatore attivo: Pre-existing Intervention
Participants will receive a comparable, pre-existing intervention not developed by the study team. |
Participants will view 1 video in the public domain with messaging on e-cigarette marketing tactics. |
|
Altro: Control Condition
Participants will receive a control condition that was not developed by the study team. |
Participants will view 4 short-form influencer-generated videos on topics that are unrelated to counter e-cigarette marketing in retail stores. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Susceptibility to use e-cigarettes among those who never used
Lasso di tempo: From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
|
Susceptibility to use e-cigarettes among those who never used [Susceptibility scores are calculated based on the following 4 items:
O'Brien EK, Baig SA, Persoskie A. Developing and Validating Measures of Absolute and Relative E-Cigarette Product Risk Perceptions: Single Items Can Be Surprisingly Comprehensive. Nicotine Tob Res. 2022;24(3):316-323. doi:10.1093/ntr/n |
From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
E-cigarette Use
Lasso di tempo: From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
|
|
From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
|
|
Intent to use e-cigarettes and cigarettes
Lasso di tempo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
Do participants plan to use e-cigarettes and cigarettes? |
From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
|
Vaping attitudes and norms
Lasso di tempo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
We will measure people's attitudes and acceptance towards vaping using: Vaping Attitudes Scale (5-point Likert-type; high score: positive attitude) and Mean Vaping Injunctive Norms Scale (3-item) |
From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
|
Pro-vaping marketing exposure (focused on retail), including marketing receptivity
Lasso di tempo: From Day 1 (Baseline/Pre-intervention) Day 31 (One-month follow-up after the treatment)
|
Can people understand and recognize e-cigarette marketing? Does it have an effect on them? |
From Day 1 (Baseline/Pre-intervention) Day 31 (One-month follow-up after the treatment)
|
|
Marketing exposure on social media
Lasso di tempo: Day 1 (Baseline/Pre-intervention)
|
Questions to assess social media use, frequency, and platforms. |
Day 1 (Baseline/Pre-intervention)
|
|
Anti-vaping content exposure
Lasso di tempo: Day 1 (Baseline/Pre-intervention)
|
Prior exposure to having seen content that dissuades people from using vapes and locations where they saw it. |
Day 1 (Baseline/Pre-intervention)
|
|
Knowledge of e-cigarette retail marketing
Lasso di tempo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
How much do people know about e-cigarette retail marketing (based on key messages and facts shown in video content)? |
From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
|
Perceived message effectiveness
Lasso di tempo: Day 1 (Immediately post-intervention)
|
We will test the effectiveness of the videos using two scales, the Message Assessment Scale for Tobacco Prevention Campaigns, and the Perceived Message Effectiveness Scale (6-item). |
Day 1 (Immediately post-intervention)
|
|
Video acceptability
Lasso di tempo: Day 1 (Immediately post-treatment)
|
We will test how much people enjoyed and connected with the videos based on a quality rating scale and a question on alternative ways to receive content. |
Day 1 (Immediately post-treatment)
|
Altre misure di risultato
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Recruitment, enrollment, and attrition
Lasso di tempo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
We want to measure recruitment and enrollment success, and how many people complete the study. |
From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
|
|
Video feasibility
Lasso di tempo: Day 1 (Immediately post-intervention)
|
We want to test whether people were able to watch the videos, how many of them they watched and for how long, and what devices they used to watch them. |
Day 1 (Immediately post-intervention)
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- 26-504
- R00CA267477 (Sovvenzione/contratto NIH degli Stati Uniti)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .